JAGCX | SCMIX | JAGCX / SCMIX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 15 years | 23 years | - |
Gain YTD | 15.912 | 15.226 | 105% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2500 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 7.52B | 14.3B | 53% |
Annual Yield % from dividends | 0.00 | 0.00 | - |
Returns for 1 year | 16.44 | 14.95 | 110% |
Returns for 3 years | 10.49 | 5.00 | 210% |
Returns for 5 years | 44.02 | 69.51 | 63% |
Returns for 10 years | 134.77 | 151.76 | 89% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
LGLV | 166.00 | 1.49 | +0.91% |
SPDR® SSGA US Large Cap Low Volatil ETF | |||
FTXH | 26.98 | 0.24 | +0.88% |
First Trust Nasdaq Pharmaceuticals ETF | |||
GEMD | 40.27 | 0.28 | +0.71% |
Goldman Sachs Access Emrg Mkts USD BdETF | |||
SLVP | 11.78 | 0.08 | +0.68% |
iShares MSCI Global Silver&Mtls Mnrs ETF | |||
IQLT | 37.06 | -0.18 | -0.48% |
iShares MSCI Intl Quality Factor ETF |